Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma
Location: United States, UT

Clinical Trial Details

Overview

Research Study Summary

Asthma. Prevention of asthma related complications.

Purpose

Do you have asthma?

Asthma can complicate your everyday life and can even be fatal. A new study is looking at two FDA approved medications. The purpose is to determine if the combination can reduce your risk of asthma related complications like, hospitalization, needing supplemental prednisone, and even asthma related death.

Receive $50.00 per visit.
Albuterol and study medications provided.
No cost to participate.
No insurance needed.
No change in your doctor.
Completely voluntary, no obligation to continue.

Patient Inclusion Criteria:

  • Be 18 or older.
  • Diagnosed with persistent asthma.
  • Have either received oral prednisone or been hospitalized for asthma in the last 52 weeks.

Patient Exclusion Criteria:

  • Have smoked for more than 10 years.

To Learn more
Phase

4

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Compensation

$50 and up

Contact

Jared Shields, Clinical Recruitment Coordinator
Optimum Clinical Research, Inc.
82 South 1100 East Suite 402
Salt Lake City, UT 84102
Phone: 801-363-7353
Fax: 801-363-7574

View Map

Research Center Information: Optimum Clinical Research, Inc.

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 181163

Date Last Changed: July 19, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.